[1]
Hong, C. et al. 2013. VALIDATION OF A PATIENT DECISION AID FOR CHOOSING BETWEEN DABIGATRAN AND WARFARIN FOR ATRIAL FIBRILLATION. Journal of Population Therapeutics and Clinical Pharmacology. 20, 3 (Sep. 2013).